Detection and Characterization of Viral Pathogens with Microfluidics
As researchers around the world mount an aggressive and sustained response to the COVID-19 pandemic, it is important to build on past successes and harness insights from current efforts to better detect and characterize pathogens, identify treatments and prepare for future outbreaks. Fluidigm microfluidics-based genomic analysis tools can support and accelerate these goals by leveraging the benefits of nanoliter-scale automated microfluidics technology with regard to throughput, flexibility, operational efficiency and cost.
About the presenter:
Director, Americas Microfluidics Commercial,
For Research Use Only. Not for use in diagnostic procedures.